Cargando…

Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach

We synthesized a set of small molecules using a molecular hybridization approach with good yields. The antiviral properties of the synthesized conjugates against the SAR-CoV-2 virus were investigated and their cytotoxicity was also determined. Among all the synthesized conjugates, compound 9f showed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wyman, Kailey A., Girgis, Adel S., Surapaneni, Pragnakiran S., Moore, Jade M., Abo Shama, Noura M., Mahmoud, Sara H., Mostafa, Ahmed, Barghash, Reham F., Juan, Zou, Dobaria, Radha D., Almalki, Ahmad J., Ibrahim, Tarek S., Panda, Siva S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501548/ https://www.ncbi.nlm.nih.gov/pubmed/36144662 http://dx.doi.org/10.3390/molecules27185923

Ejemplares similares

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2023)

Synthesis, Antibacterial Evaluation, and Computational Studies of a Diverse Set of Linezolid Conjugates
por: Bokhtia, Riham M., et al.
Publicado: (2022)

Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity
por: Hamdy, Rania, et al.
Publicado: (2021)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Antiviral activities of plant-derived indole and β-carboline alkaloids against human and avian influenza viruses
por: Hegazy, Akram, et al.
Publicado: (2023)

Spiroindole-containing compounds bearing phosphonate group of potential M(pro)-SARS-CoV-2 inhibitory properties
por: Bekheit, Mohamed S., et al.
Publicado: (2023)

New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2
por: Seliem, Israa A., et al.
Publicado: (2021)

Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
por: Bekheit, Mohamed S., et al.
Publicado: (2023)

Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
por: Fawazy, Nehmedo G., et al.
Publicado: (2022)

Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies
por: Hegazy, Akram, et al.
Publicado: (2022)

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
por: Kutkat, Omnia, et al.
Publicado: (2022)

Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold
por: Panda, Siva S., et al.
Publicado: (2023)

Azomethine Ylides—Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds
por: Panda, Siva S., et al.
Publicado: (2023)

Differential Impact of Specific Amino Acid Residues on the Characteristics of Avian Influenza Viruses in Mammalian Systems
por: Mashaal, Dayly, et al.
Publicado: (2022)

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
por: Roshdy, Wael H., et al.
Publicado: (2020)

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
por: Elagawany, Mohamed, et al.
Publicado: (2022)

3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2021)

Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid–isoniazid hybrid conjugates
por: Panda, Siva S., et al.
Publicado: (2019)

Facile synthetic approach towards vasorelaxant active 4-hydroxyquinazoline-4-carboxamides
por: Aziz, Marian N., et al.
Publicado: (2019)

An Effective and Novel Neural Network Ensemble for Shift Pattern Detection in Control Charts
por: Barghash, Mahmoud
Publicado: (2015)

Synthesis, human topoisomerase IIα inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics
por: Fawzy, Nehmedo G., et al.
Publicado: (2019)

Potential role of PIM1 inhibition in the treatment of SARS-CoV-2 infection
por: Ismail, Magda M. F., et al.
Publicado: (2023)

Innovative Hybrid Approach for Masked Face Recognition Using Pretrained Mask Detection and Segmentation, Robust PCA, and KNN Classifier
por: Eman, Mohammed, et al.
Publicado: (2023)

Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study
por: Abo Shama, Noura M., et al.
Publicado: (2022)

Plant-Based Natural Products and Extracts: Potential Source to Develop New Antiviral Drug Candidates
por: Thomas, Eyana, et al.
Publicado: (2021)

Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2′-pyrrolidine-3′,3′′-pyrrolidines]
por: Youssef, M. Adel, et al.
Publicado: (2020)

Study of Serum Leptin in Well-differentiated Thyroid Carcinoma: Correlation with Patient and Tumor Characteristics
por: Rehem, Rania Abdel, et al.
Publicado: (2014)

Protective effects of Aporosa octandra bark extract against D-galactose induced cognitive impairment and oxidative stress in mice
por: Panda, Siva S., et al.
Publicado: (2018)

β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization
por: Hamed, Mohammed I. A., et al.
Publicado: (2021)

Molecular Hybridization of Alkaloids Using 1,2,3-Triazole-Based Click Chemistry
por: Buchanan, Devan, et al.
Publicado: (2023)

Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents
por: Mashaal, Ahmed R, et al.
Publicado: (2022)

Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses
por: Mahmoud, Sara H., et al.
Publicado: (2023)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mostafa, Ahmed, et al.
Publicado: (2020)

The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
por: Dawood, Reham M, et al.
Publicado: (2022)

Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed
por: Hassany, Sahar M, et al.
Publicado: (2020)

Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties
por: Srour, Aladdin M., et al.
Publicado: (2021)

Fibrosis regression following hepatitis C antiviral therapy
por: Elsharkawy, Aisha, et al.
Publicado: (2022)

IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response
por: Panda, Debasis, et al.
Publicado: (2019)

Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2
por: Kandeil, Ahmed, et al.
Publicado: (2020)

Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt
por: El Rifay, Amira S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gj0jbvg49hiipsec2k0633c52d